These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 11149168

  • 1. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ, Trilla A, Codina C, Carné X, Ribas J, Asenjo MA.
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A, Simoni M, Cellini M, Cartabellotta A, Ballerin L, Piattella M, Putinati S.
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance.
    Martin M, Quilici S, File T, Garau J, Kureishi A, Kubin M.
    J Antimicrob Chemother; 2007 May; 59(5):977-89. PubMed ID: 17395688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
    Wu JH, Howard DH, McGowan JE, Frau LM, Dai WS.
    Clin Ther; 2004 Dec; 26(12):2153-62. PubMed ID: 15823779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK, Nopmaneejumruslers C, Chan CK.
    Am J Med; 2004 Mar 15; 116(6):385-93. PubMed ID: 15006587
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS.
    Int J Antimicrob Agents; 2004 Jun 15; 23(6):533-46. PubMed ID: 15194123
    [Abstract] [Full Text] [Related]

  • 19. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.
    Asche C, McAdam-Marx C, Seal B, Crookston B, Mullins CD.
    J Antimicrob Chemother; 2008 May 15; 61(5):1162-8. PubMed ID: 18310136
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)].
    Rev Clin Esp; 1999 Nov 15; 199(11):700-4. PubMed ID: 10638232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.